Clinical Trial

Impact of Exercise Training on Serum Glial Fibrillary Acidic Protein (GFAP), Brain Volumetry, and Functional Outcomes in Multiple Sclerosis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 13, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This single-blind, randomized controlled trial will employ a two-arm parallel design (exercise group vs. control group) with a 12-week intervention period. Randomization will be implemented using SPSS 25.0 (IBM Corporation, Armonk, NY, USA) to ensure balanced group allocation. All outcome measures will be assessed at baseline and post-intervention.
Trial Details
NCT Number NCT07521995
Lead Sponsor Firat University
Conditions Multiple Sclerosis, Exercise, Function
Enrollment 30 participants
Start Date 2026-05-01
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-13